BCPC · Nasdaq · CIK 0000009326

BALCHEM CORP

BALCHEM CORP’s most recent SEC filing in our snapshot is a Form 10-Q filed on Oct 23, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $1.0B and net income of $154.8M, according to its XBRL data on EDGAR. Its EDGAR record lists 28 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$1.0B
Net income, FY2025
$154.8M
Form 4 filings on record, past 12 months
28

Company overview

Legal name (as filed)
BALCHEM CORP
Ticker
BCPC
SEC Central Index Key (CIK)
0000009326
Industry (SIC)
Chemicals & Allied Products (code 2800)
Business address
MONTVALE, NJ
State or country of incorporation
MD
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#1280 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from BALCHEM CORP’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$799.0MFY2021$942.4MFY2022$922.4MFY2023$953.7MFY2024$1.0BFY2025
Net income
$96.1MFY2021$105.4MFY2022$108.5MFY2023$128.5MFY2024$154.8MFY2025
BCPC annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$799.0M$942.4M$922.4M$953.7M$1.0B
Net income$96.1M$105.4M$108.5M$128.5M$154.8M
Diluted EPS$2.94$3.25$3.35$3.93$4.75
Total assets$1.2B$1.6B$1.6B$1.6B$1.7B
Cash and equivalents$103.2M$66.6M$64.4M$49.5M$74.6M

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

BCPC latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 20, 202610-KAnnual report· period Dec 31, 2025Document · Index
Oct 23, 202610-QQuarterly report· period Sep 30, 2026Document · Index
Oct 23, 20268-KResults of operations· period Oct 23, 2026Document · Index
Apr 27, 2026DEF 14ADefinitive proxy statement· period Jun 18, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about BALCHEM CORP, by form type:

4 ×218-K ×710-Q ×33 ×2SCHEDULE 13G ×211-K ×1DEFA14A ×1DEF 14A ×1SCHEDULE 13G/A ×110-K ×1
BCPC recent filings
FiledFormWhat it isOriginal
Oct 23, 202610-QQuarterly report· period Sep 30, 2026Document · Index
Oct 23, 20268-KResults of operations· period Oct 23, 2026Document · Index
Sep 24, 20263Initial statement of beneficial ownership· period Sep 16, 2026Document · Index
Jul 31, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 31, 20268-KResults of operations· period Jul 31, 2026Document · Index
Jul 27, 20268-KMaterial agreement; New financial obligation· period Jul 24, 2026Document · Index
Jun 22, 20268-KShareholder vote results· period Jun 18, 2026Document · Index
Jun 18, 202611-KAnnual report of employee stock plans· period Dec 31, 2025Document · Index
Apr 30, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Apr 30, 20268-KResults of operations· period Apr 30, 2026Document · Index
Apr 29, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Apr 28, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Apr 27, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Apr 27, 2026DEF 14ADefinitive proxy statement· period Jun 18, 2026Document · Index
Apr 7, 20263Initial statement of beneficial ownership· period Apr 1, 2026Document · Index
Mar 26, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Feb 20, 202610-KAnnual report· period Dec 31, 2025Document · Index
Feb 20, 20268-KResults of operations· period Feb 20, 2026Document · Index
Feb 19, 20268-KDirector or officer change· period Feb 12, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 11, 2026Document · Index
Feb 10, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 8, 2026Document · Index
Feb 10, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 8, 2026Document · Index
Feb 10, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2025Document · Index
Feb 10, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 8, 2026Document · Index
Feb 10, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 8, 2026Document · Index
Feb 10, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 8, 2026Document · Index

Insider filing activity

28 Form 4 filings appear in BALCHEM CORP’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Chemicals & Allied Products

All 11 companies in Chemicals & Allied Products· Companies headquartered in New Jersey

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000009326 and XBRL company facts. BALCHEM CORP on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.